Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
The Lancet. Neurology
|
September 20, 2024
RAB32 mutation in Parkinson's disease
Christian Beetz, Mandy Radefeldt, Kornelia Tripolszki, et al.
Molecular Oncology
|
August 27, 2025
Expression and DNA methylation of 20S proteasome subunits as prognostic and resistance markers in cancer
Ruba Al-Abdulla, Simone Venz, Ruslan Al-Ali, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 10, 2026
Reply to: "Unravelling the Complexity of VPS16 Splicing: Clinical Implications and Unresolved Questions"
Ana Westenberger, Edgard Verdura, Mandy Radefeldt, et al.
Life (Basel, Switzerland)
|
December 23, 2023
Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients
Mandy Radefeldt, Silke Stellmacher-Kaiser, Susann Krake, et al.
Journal of Neurology
|
December 16, 2024
Genetic evidence for a link between frontotemporal dementia and Parkinson's disease: the case of RAB32 Ser71Arg
Andrea Panzavolta, Francesco Cavallieri, Franco Valzania, et al.
Clinical Genetics
|
March 1, 2022
A homozygous frame-shift variant in PROSER1 is associated with developmental delay, hypotonia, genitourinary malformations, and distinctive facial features
Azza Salah, Mohammed Almannai, Mode Al Ojaimi, et al.
Cancers
|
December 10, 2021
The HROC-Xenobank-A High Quality Assured PDX Biobank of >100 Individual Colorectal Cancer Models
Stephanie Matschos, Florian Bürtin, Said Kdimati, et al.
European Journal of Human Genetics : EJHG
|
January 27, 2025
Beyond genomics: using RNA-seq from dried blood spots to unlock the clinical relevance of splicing variation in a diagnostic setting
Aida M Bertoli-Avella, Mandy Radefeldt, Ruslan Al-Ali, et al.
International Journal of Molecular Sciences
|
April 23, 2022
The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines
Yixuan Ma, Sina Sender, Anett Sekora, et al.
International Journal of Molecular Sciences
|
April 23, 2022
Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines
Yixuan Ma, Sina Sender, Anett Sekora, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
The Lancet. Neurology
|
September 20, 2024
RAB32 mutation in Parkinson's disease
Christian Beetz, Mandy Radefeldt, Kornelia Tripolszki, et al.
Molecular Oncology
|
August 27, 2025
Expression and DNA methylation of 20S proteasome subunits as prognostic and resistance markers in cancer
Ruba Al-Abdulla, Simone Venz, Ruslan Al-Ali, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 10, 2026
Reply to: "Unravelling the Complexity of VPS16 Splicing: Clinical Implications and Unresolved Questions"
Ana Westenberger, Edgard Verdura, Mandy Radefeldt, et al.
Life (Basel, Switzerland)
|
December 23, 2023
Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients
Mandy Radefeldt, Silke Stellmacher-Kaiser, Susann Krake, et al.
Journal of Neurology
|
December 16, 2024
Genetic evidence for a link between frontotemporal dementia and Parkinson's disease: the case of RAB32 Ser71Arg
Andrea Panzavolta, Francesco Cavallieri, Franco Valzania, et al.
Clinical Genetics
|
March 1, 2022
A homozygous frame-shift variant in PROSER1 is associated with developmental delay, hypotonia, genitourinary malformations, and distinctive facial features
Azza Salah, Mohammed Almannai, Mode Al Ojaimi, et al.
Cancers
|
December 10, 2021
The HROC-Xenobank-A High Quality Assured PDX Biobank of >100 Individual Colorectal Cancer Models
Stephanie Matschos, Florian Bürtin, Said Kdimati, et al.
European Journal of Human Genetics : EJHG
|
January 27, 2025
Beyond genomics: using RNA-seq from dried blood spots to unlock the clinical relevance of splicing variation in a diagnostic setting
Aida M Bertoli-Avella, Mandy Radefeldt, Ruslan Al-Ali, et al.
International Journal of Molecular Sciences
|
April 23, 2022
The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines
Yixuan Ma, Sina Sender, Anett Sekora, et al.
International Journal of Molecular Sciences
|
April 23, 2022
Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines
Yixuan Ma, Sina Sender, Anett Sekora, et al.
Page
of 3